Analytical and Biological Characterization of a Noninnovator Insulin Glargine and the Originator Drug Product
Letter
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
funding provided via
published in
Research
keywords
-
analytical characterization; biosimilar; biotechnology; insulin analogues; mass spectrometry; protein structure insulin glargine; antidiabetic agent; biosimilar agent; insulin glargine; analytical parameters; biological activity; clinical evaluation; cost effectiveness analysis; drug formulation; Escherichia coli; high performance liquid chromatography; insulin dependent diabetes mellitus; Letter; matrix assisted laser desorption ionization time of flight mass spectrometry; molecular weight; non insulin dependent diabetes mellitus; physical chemistry; polyacrylamide gel electrophoresis; practice guideline; regulatory mechanism; ultra performance liquid chromatography; ultraviolet spectroscopy; Western blotting; chemistry; human; Mexico; Biosimilar Pharmaceuticals; Humans; Hypoglycemic Agents; Insulin Glargine; Mexico
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue